Suven Life Sciences Limited
Records under this name other than the patents Suven Life Sciences Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 31 patents it holds.
Back to Suven Life Sciences Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,138,366 | Process for the preparation of malathion and its intermediate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,783,506 | Process for the large scale production of 1H-[1,2,3]triazole and its intermediate 1-benzyl-1H-[1,2,3]triazole Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,252,981 | Methods of Synthesis of (1R,2R,5R)-5-Amino-2-Methylcyclohexanol Hydrochloride and Intermediates Useful Therein Formerly held In force · High confidence | In force | High confidence | |
| US 9,957,257 | Amide compounds as 5-HT4 receptor agonists Lapsed on the fee record Ended May 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2026 | From the USPTO record |
| US 7,388,024 | Indeno[2,1A]indenes and isoindolo[2,1-A]indoles Term ended Term ended Dec 30, 2024 · From the USPTO record | Term ended | Term ended Dec 30, 2024 | From the USPTO record |
| US 8,143,303 | Carbazole derivatives as functional 5-HT6 ligands Lapsed on the fee record Ended Mar 27, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 27, 2024 | From the USPTO record |
| US 7,385,072 | Methods for the preparation of Entacapone Term ended Term ended Dec 29, 2023 · From the USPTO record | Term ended | Term ended Dec 29, 2023 | From the USPTO record |
| US 7,317,035 | Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them Term ended Term ended Nov 17, 2023 · From the USPTO record | Term ended | Term ended Nov 17, 2023 | From the USPTO record |
| US 8,003,670 | Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands Lapsed on the fee record Ended Aug 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 23, 2023 | From the USPTO record |
| US 7,998,981 | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands Lapsed on the fee record Ended Aug 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 16, 2023 | From the USPTO record |